Please assess the completion status of the following clinical trial:

Trial Title: Restylane-L for Correction of Infraorbital Hollows

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Moderate or severe infraorbital hollows with no more than one grade difference between the left and right side at baseline as assessed by the blinded evaluator.~* Males or non-pregnant, non-breastfeeding females, over the age of 21.~* Intent to undergo correction of both orbital hollows.~Exclusion Criteria:~* Known/previous allergy or hypersensitivity to any injectable hyaluronic acid (HA) gel or to gram positive bacterial proteins.~* Known/previous allergy or hypersensitivity to local anesthetics, e.g. lidocaine or other amide-type anesthetics.~* Previous deep and/or superficial facial dermal therapies.~* Active or a history of recurrent or chronic infraorbital edema or rosacea or uncontrolled severe seasonal allergies.

- Gender: ALL
- Minimum Age: 22 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Restylane-L Treatment (Type: EXPERIMENTAL): Restylane-L® injected with optional touch-up at 1 month and optional retreatment at 12 months.
- No Treatment Control (Type: NO_INTERVENTION): No treatment control with optional treatment at 12 months.

Based on this trial design, predict the completion outcome and termination type (if applicable).